Abstract
Higher organisms such as mammals exist in a symbiotic relationship with their gut microbiota, formed from a diverse and highly metabolically active consortium of species. The gut microbiota, in addition to their ability to process dietary derived material, are also capable of performing a range of biotransformations on xenobiotics, such as drugs and their metabolites, in ways that can affect absorption and bioavailability. The potential for the gut microflora to influence drug metabolism and toxicity in unexpected ways is discussed.
Keywords: Drug metabolism, bioavailability, gut microbiota, superorganisms, population differences, diet
Current Pharmaceutical Design
Title: The Role of Gut Microbiota in Drug Response
Volume: 15 Issue: 13
Author(s): I. D. Wilson and J. K. Nicholson
Affiliation:
Keywords: Drug metabolism, bioavailability, gut microbiota, superorganisms, population differences, diet
Abstract: Higher organisms such as mammals exist in a symbiotic relationship with their gut microbiota, formed from a diverse and highly metabolically active consortium of species. The gut microbiota, in addition to their ability to process dietary derived material, are also capable of performing a range of biotransformations on xenobiotics, such as drugs and their metabolites, in ways that can affect absorption and bioavailability. The potential for the gut microflora to influence drug metabolism and toxicity in unexpected ways is discussed.
Export Options
About this article
Cite this article as:
Wilson D. I. and Nicholson K. J., The Role of Gut Microbiota in Drug Response, Current Pharmaceutical Design 2009; 15 (13) . https://dx.doi.org/10.2174/138161209788168173
DOI https://dx.doi.org/10.2174/138161209788168173 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chronopharmaceutical Delivery of Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry From Test Tube to Clinical Trial; Promising Herbs with NF-κB and COX- 2 Activity
Current Immunology Reviews (Discontinued) Beta-blockers in Children with Duchenne Cardiomyopathy
Reviews on Recent Clinical Trials Combined Transcriptomic and Proteomic Analyses of Cerebral Frontal Lobe Tissue Identified RNA Metabolism Dysregulation as One Potential Pathogenic Mechanism in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Current Neurovascular Research Postoperative Atrial Fibrillation - What Do We Really Know?
Current Vascular Pharmacology Overview on Radiolabel-Free in vitro Assays for GPCRs
Mini-Reviews in Medicinal Chemistry Applications of Artificial Neural Networks in Medical Science
Current Clinical Pharmacology Cardio-vascular Activity of Catestatin: Interlocking the Puzzle Pieces
Current Medicinal Chemistry Pathophysiology of Sepsis in the Elderly: Clinical Impact and Therapeutic Considerations
Current Drug Targets Relationship between Augmentation Index and Wall Thickening Fraction during Hypotension in an Animal Model of Myocardial Ischemia-Reperfusion and Heart Failure
Current Hypertension Reviews Controversies About the Chromosomal Stability of Cultivated Mesenchymal Stem Cells: Their Clinical Use is it Safe?
Current Stem Cell Research & Therapy Diuretic-Associated Electrolyte Disorders in the Elderly: Risk Factors, Impact, Management and Prevention
Current Drug Safety Angiotensin II Roles in Human Vascular Tone Control
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Mitochondrial Dysfunction during Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Update in the Management of Diastolic Heart Failure
Current Vascular Pharmacology Lipid Lowering Drugs and Gallstones: A Therapeutic Option?
Current Pharmaceutical Design The <i>in Vivo</i> Effects of <i>Cassia Abbreviata Oliv.</i>, on Sperm Parameters And Testicular Histology of The Male Wistar Rat
Current Traditional Medicine Lung Ultrasound in the Management of Acute Decompensated Heart Failure
Current Cardiology Reviews Opportunities for Nano-Formulations in Type 2 Diabetes Mellitus Treatments
Current Pharmaceutical Biotechnology The Role of Vasopressin in Affective Disorders: Possible Targets of Intervention
Central Nervous System Agents in Medicinal Chemistry